Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA cross-linking refers to the formation of covalent bonds between two nucleotides within the same strand (*intrastrand*) or across complementary strands (*interstrand*) in double-stranded DNA. This process can be triggered by exogenous agents such as chemotherapeutic alkylating agents or endogenous metabolic byproducts. Cross-links disrupt essential cellular processes like replication and transcription, often resulting in cell cycle arrest and activation of apoptotic pathways. In cancer therapy, bifunctional alkylating agents exploit this mechanism to selectively kill rapidly dividing tumor cells by overwhelming their repair capacity, ultimately inducing apoptosis[1][2]. However, because "DNA cross-linking leading to apoptosis" describes a **cellular process** rather than a discrete molecular target such as an enzyme or receptor, it is not considered a canonical therapeutic target itself but rather an outcome exploited by certain drugs[2]. If you are seeking structured information for drug targets involved in this pathway—such as specific enzymes responsible for repairing these lesions (e.g., Fanconi anemia proteins) or proteins mediating apoptosis—you should specify those molecules individually. **Note:** The entry "DNA cross-linking leading to apoptosis" is not itself a canonical molecular target but describes a mechanism/process; therefore `is_target` is false and `is_incorrect` is true according to your conventions.
Induction of covalent bonds between nucleotides on the same or opposite strands of DNA, leading to inhibition of replication/transcription and triggering apoptosis[1][2].
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA cross-linking.